Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-04

Clinical Trial Update: Methylene Blue for the Treatment of Septic Shock [Phase 3]

View source ↗

Summary

Phase 3 trial of methylene blue for septic shock has completed, with the update indicating completion but no results are provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHYLENE BLUE (METHYLENE BLUE)

Snippet

Sponsor: Northern Jiangsu People's Hospital | Conditions: Septic Shock | Phase 3 | Status: COMPLETED